http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0620108-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24b4aee11752e7c69e485a21d0282e12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616 |
| filingDate | 2006-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33754ff530b705d6aecdc90b97aa8c02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c15e199b4f85a374f19f052fc79ee55c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adf8dd3f1f21a8236ba2f4edf4e4a1eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fa51d86f4b8441cd2697ea5ce6ab003 |
| publicationDate | 2011-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI0620108-A2 |
| titleOfInvention | pharmaceutical compositions comprising calcium antagonist substances combined with platelet antiaggregants for use in systemic arterial hypertension and prevention of ischemic vascular events |
| abstract | PHARMACEUTICAL COMPOSITIONS UNDERSTANDING CALCIUM ANTAGONIST SUBSTANCES COMBINED WITH PLAQUETARY ANTIGREGANTS FOR USE IN SYSTEMIC ARTERIAL HYPERTENSION AND PREVENTION OF VESCULAR EVENTS The pharmaceutical industry is related to the pharmaceutical industry and to the pharmaceutical industry. and in particular the prevention of vascular events of ischemic origin. More specifically this is about a composition formed by an antagonistic calcium hypotensive substance in combination with a platelet antiaggregating agent. The composition is characterized in that this combination or combination consists of a selected calcium channel antagonist substance known as Amlodipino besylate and a platelet antiaggregant known as sour acetylsalicylic acid; They produce a product with synergistic effect for the treatment of arterial systemic hypertension and prevent the risk of vascular events of ischemic origin, with minor side effects. |
| priorityDate | 2005-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 117.